Children's Healthcare of Atlanta
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, Children's Healthcare of Atlanta sits in the top decile of US sponsors by registered trial count (#280 of 15,742 sponsors by registered trial count).
Children's Healthcare of Atlanta: 80 sponsored US clinical trials, 2 recruiting.
Children's Healthcare of Atlanta sponsors 80 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 29 completed. 2 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Congenital Disorders, with 3 trials.
Top-decile sponsor footprint
Children's Healthcare of Atlanta ranks in the top decile of sponsors by registered trial count (#280 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
29 of 77 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (37.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
80 total, page 1 of 2
BFRT in Adolescents After ACL Reconstruction
NCT04390035
Gabapentin Premedication to Reduce Postoperative Pain for Pediatric Tonsillectomy
NCT03625011
Comparison of Two Artificial Intelligence Scribe Products on Pediatric Subspecialty Provider Wellness and Experience, Patient Satisfaction, and Efficiency.
NCT07157943
Impact of Digital Ambient EXperience on Pediatric Subspecialist Documentation Burden
NCT06812234
Hemostatic Profiles in Pediatric CKD
NCT05064267
Preparing Children for Anesthesia With an Educational Pop-Up Book
NCT04796077
Pediatric Acute Kidney Injury in COVID-19
NCT04466306
Music Therapy With Intubated and Sedated Pediatric Patients
NCT03629145
Gabapentin Premedication for ACL Reconstruction: RCT
NCT03417479
Pilot Study of the Safety of a Daily Ethanol Lock for Urinary Catheters in Critically Ill Children
NCT01865708
Choosing Opioid Management for Pain and Analyzing Acute Chest Syndrome (ACS) Rates Equally
NCT01380197
Aprotinin in Neonates Undergoing Cardiopulmonary Bypass
NCT00469742
Primary Palatoplasty in Pediatric Patients - A Retrospective Review of Surgical Outcomes
NCT01380171
Femoral Arterial Cannulation
NCT00486096
Review of Descending Aortic Flow Reversal in Total Anomalous Pulmonary Venous Connection
NCT00486070
Study of High Blood Sugars and Insulin in Hospitalized, Critically Ill Children
NCT00487006
Lidocaine Lubricant in Pediatric Urethral Catheterization
NCT00596375
Chlorhexidine Swabs Effectiveness in Reducing Blood Stream Infections
NCT00485992
Home Inotropic Therapy in Children
NCT00327899
Evaluation of Functional MRI and DTI (Imaging Techniques) in Children With Epilepsy and Focal Brain Lesions
NCT00229840
Managing Cyanosis Following Bidirectional Glenn Operation
NCT00327886
Surgical Outcomes in Pediatric Patients With Coarctation and VSD
NCT00327795
Allograft Fibrosis Following Pediatric Cardiac Transplantation
NCT00328185
Pulse Oximetry Readings and Hourly Variation in Oximetry Readings With CHD
NCT00261989
Retrospective Evaluation of Carvedilol Versus Captopril in CHF Patients
NCT00249067
Feeding After Neonate Surgery Review
NCT00229866
Death Following Congenital Heart Surgery
NCT00215072
Patient Plasma Response and Outcome in Septic Shock With Thrombocytopenia Associated Multiple Organ Failure in Children
NCT00118664
Cardiac Tumors in Children
NCT00215085
Optimal Timing for Repair of Left to Right Shunt Lesions
NCT00229827
Chylothorax Following Heart Surgery
NCT00215098
Optimal Timing for Repair of Right-to-Left Shunt Lesions
NCT00268099
Relationship of Brain Natriuretic Peptide (BNP) Levels to Cardiac Diagnosis, Operation Performed, Post-operative Course and Outcome
NCT00238810
Relationship Between EBV and PTLD
NCT00215033
Child With Anomalous Drainage of IVC to Left Atrium
NCT00229905
Impact of Race and Re-Transplantation
NCT00229788
Study of Patients With Acute Renal Failure on CVVH
NCT00207909
Incisions for Cardiac Surgery
NCT00229892
Ultrasound Guided Vascular Access in Pediatric Intensive Care Patients
NCT00207883
Rare Tumor Case Review
NCT00229879
Pulmonary Hypertension in Trisomy 21 Patients
NCT00478296
Infant Medical Records: Case Report Proposal
NCT00268060
Neuroendocrine Dysfunction in Critically Ill Pediatric Patients
NCT00207896
Thoracoscopic Vascular Rings Chart Review
NCT00229853
Daclizumab Experience in Pediatric Heart Transplant
NCT00486057
Resynchronization of Left Ventricular Contraction After Reimplantation of Anomalous Left Coronary Artery
NCT00268112
Cryoablation Versus Radiofrequency Ablation
NCT00238823
Frequency of Accessing Central Lines for Blood Samples
NCT00366314
Left Ventricular Aneurysms in Children
NCT00268034
MRI Assessment of RV Function: Patients With TOF or Aortic Coarctation
NCT00277901
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 3 | 1 |
| Phase 4 | 1 |
Therapeutic Areas
Where Children's Healthcare of Atlanta enrollment is open (later-stage tilt)
2 recruiting of 80 indexed (3% open); 29 completed (36%).
Phase mix: 2 late (III/IV) vs 1 early (I/II) (later-stage heavy).
Top condition: Congenital Disorders (3 trials), 8 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Children's Healthcare of Atlanta: open-pipeline peers nationwide
Peers matched on 80 registered trials and 3% open enrollment, not the therapeutic-area sidebar.
Children's Healthcare of Atlanta sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 80 trials (± recruiting share)
- BioMarin Pharmaceutical · 80 trials · 16% recruiting
- EMD Serono Research & Development Institute · 81 trials · 11% recruiting
- The University of Tennessee, Knoxville · 81 trials · 7% recruiting
- TriHealth · 81 trials · 2% recruiting
Sponsors near 3% open enrollment (± trial volume)
- Harvard School of Public Health (HSPH) · 3% recruiting · 40 trials
- Ethicon Endo-Surgery · 3% recruiting · 39 trials
- Cumberland Pharmaceuticals · 2% recruiting · 43 trials
- Appalachian State University · 3% recruiting · 37 trials
Related
What to do with this Children's Healthcare of Atlanta page
80 registered trials is a research-attention snapshot, not an endorsement of Children's Healthcare of Atlanta or any single study.
- 2 of Children's Healthcare of Atlanta's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Congenital Disorders is the condition Children's Healthcare of Atlanta studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Congenital Disorders trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Children's Healthcare of Atlanta pipeline card: 80 registered trials from official public datasets.Report a data error.